MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 47 filers reported holding MEI PHARMA INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $106,000 | -15.2% | 73,394 | +3.2% | 0.00% | – |
| Q3 2016 | $125,000 | +28.9% | 71,110 | -0.1% | 0.00% | – |
| Q2 2016 | $97,000 | +6.6% | 71,171 | -1.8% | 0.00% | – |
| Q1 2016 | $91,000 | -27.2% | 72,447 | -7.3% | 0.00% | – |
| Q4 2015 | $125,000 | +5.9% | 78,163 | +3.8% | 0.00% | – |
| Q3 2015 | $118,000 | -10.6% | 75,299 | -2.6% | 0.00% | – |
| Q2 2015 | $132,000 | +8.2% | 77,291 | +13.7% | 0.00% | – |
| Q1 2015 | $122,000 | -52.3% | 67,987 | +13.4% | 0.00% | – |
| Q4 2014 | $256,000 | -5.9% | 59,944 | +52.0% | 0.00% | – |
| Q3 2014 | $272,000 | +14.3% | 39,447 | +5.2% | 0.00% | – |
| Q2 2014 | $238,000 | -93.7% | 37,507 | -88.9% | 0.00% | -100.0% |
| Q1 2014 | $3,749,000 | +45.0% | 336,835 | +4.4% | 0.00% | 0.0% |
| Q4 2013 | $2,585,000 | -16.1% | 322,727 | +17.9% | 0.00% | 0.0% |
| Q3 2013 | $3,080,000 | +78.3% | 273,795 | +13.1% | 0.00% | 0.0% |
| Q2 2013 | $1,727,000 | – | 242,163 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 3,459,124 | $9,132,000 | 11.08% |
| Sio Capital Management, LLC | 2,373,841 | $6,267,000 | 2.28% |
| Vivo Capital, LLC | 5,778,106 | $15,254,000 | 1.95% |
| BVF INC/IL | 2,978,708 | $7,864,000 | 1.03% |
| Boxer Capital, LLC | 2,913,091 | $7,691,000 | 0.95% |
| NEA Management Company, LLC | 5,720,572 | $15,102,000 | 0.60% |
| Perceptive Advisors | 4,400,440 | $11,617,000 | 0.44% |
| INDUS CAPITAL PARTNERS, LLC | 631,513 | $1,667,000 | 0.30% |
| BAILARD, INC. | 381,292 | $1,007,000 | 0.07% |
| KNOTT DAVID M | 38,590 | $102,000 | 0.05% |